Evidence map›Paper›PMID 40736264›Full record

ArticleMicrobiology spectrum2025

Commensal colonization of

Kelsey E Mauk, Pedro Miramón, Michael C Lorenz, Léa Lortal, Julian R Naglik, Bernhard Hube, Lynn Bimler, Farrah Kheradmand, David B Corry

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. mBio · 2026
    Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kelsey E MaukDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-5985-4148
Pedro MiramónDepartment of Microbiology and Molecular Genetics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.ORCID 0000-0002-6867-7697
Michael C LorenzDepartment of Microbiology and Molecular Genetics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.ORCID 0000-0002-7881-8027
Léa LortalCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom.ORCID 0009-0004-6221-7763
Julian R NaglikCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-8072-7917
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoll Institute (HKI), Jena, Germany.ORCID 0000-0002-6028-0425
Lynn BimlerDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-7473-9698
Farrah KheradmandDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.
David B CorryDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-9729-1016

Funding

Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
RESEARCH TRAINING IN LUNG DISEASET32HL007747 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI ROSAS, IVAN O. · 1993 to 2020
$5.1M
Pathogenesis of Polymicrobial Cerebritis-Related DementiaR01AI135803 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2018 to 2022
$3.8M
The Clinical Translational Research Certificate of Added Qualification ProgramT32GM136554 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Melissa Suter, IGNATIA B VAN DEN VEYVER · 2020 to 2026
$3.0M
Collaborative Research Training in Thrombosis and InflammationT32HL139425 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Miguel Angel Cruz, ROLANDO E RUMBAUT · 2018 to 2026
$2.4M
Role of Let-7 as genetic modifier of Alzheimer's DiseaseR01HL140398 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, RODRIGUEZ, ANTONY · 2018 to 2022
$2.4M
Mechanism of Fungal Virulence Inhibition by a Bacterial PeptideR01AI183606 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Danielle A Garsin, Michael C Lorenz · 2024 to 2026
$2.2M
IL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1M
National Institutes for Health and Care Research DE022550NHLBI NIH HHS R01 HL140398NHLBI NIH HHS T32 HL007747NHLBI NIH HHS T32 HL139425NIAID NIH HHS R01 AI135803NIAID NIH HHS R01 AI183606NIDCR NIH HHS R01 DE022550NIDCR NIH HHS R37 DE022550NIGMS NIH HHS T32 GM136554NIH HHS T32GM136554, HL140398, R01AI135803, K01AG083119, T32HL139425, T32HL007747Wellcome TrustWellcome Trust 214229_Z_18_Z
6 · The paper itself

Abstract

The ubiquitous fungal pathogen

Indexed as

Candida albicansCandidiasisFungal ProteinsGastrointestinal TractAnimalsFemaleGastrointestinal MicrobiomeMiceSpecific Pathogen-Free OrganismsSymbiosisFungal ProteinsCandida albicansintestinal colonizationvirulence factors

Identifiers

PMID40736264
PMCPMC12403622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.